L ong-term exposure to particulate air pollution has been associated with higher incidence of stroke 1 and impaired cognitive function in older adults. 2,3 Long-term exposures have also been associated with changes in cerebral hemodynamics, 4 impaired microvascular reactivity, 5 and greater carotid atherosclerotic burden. 6 Air pollution has been hypothesized to affect the central nervous system through activation of systemic inflammatory pathways and vascular dysfunction. 7 Particulate air pollution is a pervasive component of urban and suburban ambient air pollution. Animal models have shown that particles can translocate from the nose via the olfactory nerve into the brain, and evidence of these particles has been found in the striatum, frontal cortex, and cerebellum. 8 However, it is not known whether long-term exposures to air pollution at urban background levels are related to measures of structural integrity and atrophy in the brains of older adults.
Materials and Methods

Study Participants
The design of the Framingham Offspring Study has been detailed previously. 10, 11 Community-dwelling participants living in the New England Region with no history of dementia, stroke, or transient ischemic attack who attended the seventh examination (1998) (1999) (2000) (2001) were aged ≥60 years at the time of MRI and were eligible for inclusion in this study (n=943). All participants provided written informed consent, and the Institutional Review Boards at Beth Israel Deaconess Medical Center and Boston Medical Center approved the protocol.
Exposure Assessment
PM 2.5 Satellite Data
Participant primary addresses at the seventh examination were geocoded using ArcGIS 10 (ESRI, Redlands, CA), and census tract median household income was assigned (US Census 2000). Beginning in the year 2000, Moderate Resolution Imaging Spectroradiometer satellite-derived Aerosol Optical Density measurements were used to predict daily PM 2.5 concentration across New England as previously described. 12, 13 Near Roadway Exposure Residential proximity to the nearest A1, A2, or A3 roadway was determined by US Census Features Class in ArcGIS. We categorized proximity based on the following cut points: <50, 50 to <100, 100 to <200, 200 to <400, and 400 to <1000 m. We also evaluated the continuous association between the natural logarithm of proximity to a major roadway and neuroimaging outcomes because we have previously reported that this exposure and mortality were linearly associated. 12 Participants living further than 1000 m from a major road in rural areas were excluded in primary analyses because the exposures of individuals living in exurb areas beyond 1000 m away from a major roadway are likely to be different from those of people living in urban and suburban areas.
Volumetric Brain MRI
TCBV, HV, and WMHV assessments and inter-rater reliability have been described previously. [14] [15] [16] [17] Total cranial volume was determined by manual delineation of the intracranial vault, and total brain parenchymal volume was determined by mathematical modeling. TCBV was then computed as a ratio of brain parenchymal volume:total cranial volume. The T2-weighted double spin-echo coronal sequences were acquired in 4-mm contiguous slices. Extensive WMHV (EXT-WMHV) was determined as a binary outcome by whether the log(WMHV/total cranial volume) was >1 SD above the age-adjusted mean in this cohort. 10, 18 The presence of CBI was determined manually on the basis of size (>3 mm), location, and characteristics of the lesions. 19
Additional Covariates
History of cardiovascular disease was determined as previously described. 20 Prevalent diabetes mellitus was defined as a fasting glucose ≥126 mg/dL or oral hypoglycemic or insulin use at an examination or any previous history of diabetes mellitus (excluding gestational diabetes). Smoking status (never, current, and former), pack-years smoked (<10 years, ≥10 years, and missing), education (no high school, high school, some college, bachelors or higher), and alcohol intake (0, 1-7 drinks/wk, and 7-14, ≥15) were self-reported. Fasting homocysteine was measured in plasma. Systolic and diastolic seated blood pressures were calculated as the mean of 2 measurements taken during the clinical examination.
Statistical Methods
Linear and logistic regression models were used to evaluate continuous outcomes (TCBV, HV, and WMHV) and dichotomous outcomes (EXT-WMHV and CBI), respectively. We first adjusted for age at MRI, [age at MRI] 2 , sex, time from examination 7 to MRI, median household income, date of MRI, smoking status, pack-years smoked, education, alcohol intake, and sine and cosine of MRI date to account for seasonal trends (model 1). We then added covariates thought to be potential confounders that could also be mediators of the associations between particulate air pollution and brain structure, including natural logarithm of homocysteine, systolic blood pressure, diabetes mellitus, cardiovascular disease, history of atrial fibrillation, hypertension medications, and obesity (body mass index ≥30 kg/m 2 ) (model 2). We tested whether observed associations differed by factors related to biological susceptibility and socioeconomic position as an evaluation of effect modification using cross-product terms for sex, diabetes mellitus, obesity, current and former smoking (versus never smoking), and median household income <25th percentile (≤$44 901).
In sensitivity analyses, we accounted for clustering by census tract to further control confounding by socioeconomic position using generalized estimating equations with exchangeable working correlation matrix. Nonlinearity was evaluated using restricted cubic splines with knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. We evaluated associations with PM 2.5 restricting to participants living within 1000 m of a major road. We also considered whether adjusting for CBI altered findings for associations between exposures of interest and TCBV. 16 Models of PM 2.5 were scaled to 2 μg/m 3 , which approximates the interquartile range (1.7 μg/m 3 ). We present the results of log-linear residential proximity to major roadway within 1000 m analyses for an interquartile range. All analyses were performed in SAS version 9.3 or STATA version 12. Plots were created using the POSTRCSPLINE package in Stata. 21 Table 1 shows population characteristics. The median (interquartile range) of PM 2.5 exposure was 11.1 (1.7) μg/m 3 .
Results
Participants lived a median distance (25th to 75th percentile) from a major road of 173 (48-415) m ( Table 2 ). The Spearman rank correlation between the natural logarithm of residential distance from a major road and PM 2.5 was −0.15.
Higher PM 2.5 was associated with smaller TCBV and 1.46 times (95% confidence interval [CI], 1.10 to 1.94) higher odds of CBI (Tables 3 and 4 ). A 2-μg/m 3 increase in PM 2.5 was associated with a 0.32 U difference in TCBV (95% CI, −0.59 to −0.05). There was no clear pattern of association between PM 2.5 and HV, WMHV, or EXT-WMHV. An interquartile range difference in residential proximity to a major road was associated with 0.10 (95% CI, 0.01 to 0.19) higher WMHV. A similar pattern was observed with categories of distance. However, there was no evidence of an association between proximity to a major road and EXT-WMHV, or was it associated with TCBV, HV, or CBI.
There was no evidence of effect modification for the observed associations by sex, diabetes mellitus diagnosis, obesity, smoking, or median income below the 25th percentile.
Only the association between PM 2.5 and TCBV met criteria for significant deviation from linearity, suggesting a stronger association at lower exposure levels and wide CIs at high levels ( Figure I in the online-only Data Supplement). We found Table 3 no material differences when we considered restricting PM 2.5 analyses to regions within 1000 m of a major road or clustering by socioeconomic position. Adjustment for covert brain injury did not alter the association between PM 2.5 and TCBV.
. Associations Between Exposures and Continuous Volumetric Outcomes
Discussion
In this study, we observed that an increase in PM 2.5 within the range of exposures observed at urban and suburban background levels in New England was associated with smaller −0.32 (95% CI, −0.59 to −0.05) TCBV and with 1.46 times (95% CI, 1.10 to 1.94) higher odds of CBI. These findings support the hypothesis that higher long-term exposures to ambient air pollution are associated with structural changes in the brain that could precede cognitive impairment and overt cerebrovascular damage. [22] [23] [24] To our knowledge, there are no published studies of associations between air pollution and brain volume or CBI in older adults. Although CBI may appear asymptomatic, these small infarcts typically located in deep regions of the brain have been associated with neurological abnormalities, poorer cognitive function, 25 onset of dementia, 24 and are thought to reflect small-vessel disease. 26 Smaller TCBV has been associated subsequent stroke among Framingham Offspring participants 27 and also with poorer performance on tests of attention, executive, and visuospatial function. 16 The magnitude of association that we observed for a 2-μg/m 3 increase in PM 2.5 was similar to ≈1 year of brain aging computed as the ratio of the coefficients for PM 2.5 and age in the model. Adjustment for CBI did not alter this association, suggesting that atrophy was independent of the presence of asymptomatic injury and not merely a direct result of the presence of cerebral infarction.
The mechanisms through which air pollution may affect brain aging remain unclear, but systemic inflammation resulting from deposition of fine particles in alveoli is likely important. Upregulation of a proinflammatory state has been associated both with elevated risk of stroke 7,28 and cognitive decline. 29 Circulating levels of biomarkers indicative of systemic inflammation have been associated with lower brain volume. 30 Our findings are largely consistent with previous studies showing that long-term exposure to ambient air pollution is associated with vascular impairment. 4, 5, 12 Several previous studies have reported associations between long-term pollution exposure and living close to major roads with incident stroke 1, 31, 32 and poorer cognitive function in older adults. 2, 3, 33 Living in a high air pollution region in Mexico City was associated with greater accumulation of 42-amino acid form of β-amyloid in the frontal cortex and hippocampus than living in a nonpolluted area. 34 Although evidence on the associations between long-term air pollution exposures and white matter damage is limited, an ecological study in Mexico reported associations between higher levels of air pollution and white matter damage in children and dogs. 35 Our findings of a positive association between WMHV and living further from a major road but no association with EXT-WMHV were unexpected. However, among Framingham Offspring Study participants, EXT-WMHV was associated with poorer cognitive function 18 and elevated risk of stroke 10 but WMHV was not, suggesting a threshold for these associations. Different findings may have distinct underlying pathophysiologic mechanisms. To evaluate this, it will 
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require additional studies in experimental models designed to address these questions. There were some differences in associations we observed for PM 2.5 and residential proximity to a major roadway. Although both capture features of long-term exposure to ambient air pollution, proximity is an integrated measure of exposure to traffic, which includes vehicle emissions, noise, ultrafine particles, road dust, and gaseous pollutants such as nitrogen dioxide, carbon monoxide, and volatile organic compounds but does not specifically account for the intensity of traffic or meteorologic conditions at a given location. In contrast, modeled PM 2.5 incorporates both locally and regionally generated air pollution. Hence, they represent different aspects of ambient pollutant exposures.
Our study is not without limitations. Although we accounted for individual-level and area-level characteristics of socioeconomic position, there may be residual confounding. However, the results from our analysis taking spatial clustering into account were similar to our primary results, and previous literature using modeled PM 2.5 has also shown that correlations between socioeconomic position and PM 2.5 are low within urban areas. 36 The Framingham Offspring population comprised mostly white participants. Therefore, these results may not be generalizable to other populations. Recent addresses were stable, with 91% of participants reporting the same address at the sixth and seventh examination cycles. Our PM 2.5 data are based on an average for the year 2001 similar to other large epidemiological studies. 12, 31 This approach limits the influence of secular trends in exposure, while capturing the spatial distribution of average PM 2.5. This study also has several strengths, including a relatively large, communitybased sample, inclusion of both men and women, quantitative brain MRI, and individual-level estimates of exposures.
Conclusions
We observed evidence suggesting that long-term exposure to PM 2.5 is associated with lower TCBV and more CBI among a community-based sample of participants free of dementia and stroke. These findings suggest that relatively low urban background levels of particulate air pollution may contribute to the acceleration of atrophic changes and small-vessel disease in older adults. Additional studies will be necessary to confirm or refute these findings, extend the work to include longitudinal assessments, and to determine factors that mediate this association.
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None. Figure I : Non-linear association between PM 2.5 and total cerebral brain volume Model 1 adjusted results for association between PM 2.5 (5 knots) and total cerebral brain volume. The spline indicates a steeper slope at lower levels of exposures. High levels of exposure were associated with higher brain volume, though confidence intervals in this range of the data were wide. Whether this pattern is due to a leveling off in the exposure-response relationship, the influence of outliers, or residual confounding remains unclear. the patients who experienced an event, 27.3% (n=1639) died in hospital or within 7 days of discharge. The 30-day cumulative incidence of ischemic stroke among new users of warfarin was 0.5% (n=721), increasing to 2.0% (n=2,917) after 1 year, 2.7% (n=4067) after 2 years, and 4.0% (n=6006) after 5 years. The risk was highest during the first 30 days of warfarin therapy: 6.0% PPY (95% confidence interval, 5.5%-6.4%) versus 1.6% PPY (95% confidence interval, 1.5%-1.6%) during the remainder of the 5-year follow-up (Table 2; Figure) .
SUPPLEMENTAL MATERIAL Supplemental
Crude 5-year rates of ischemic stroke increased significantly as CHADS 2 scores increased (P<0.0001; Table 2 ; Figure I in the online-only Data Supplement) and among those with a history of stroke (P<0.001; Table 2 ; Figure II in the onlineonly Data Supplement). A sensitivity analysis demonstrated no difference in stroke rates according to timing of warfarin initiation after atrial fibrillation diagnosis ( Table 2 ). Relative to patients who did not experience a stroke, those who did were less likely to have received an international normalized ratio test in the preceding 14 days (Table II in the online-only Data Supplement). Few patients received heparin or antiplatelet therapy (Table 1 ).
Discussion
In this population-based study, the rate of ischemic stroke in older patients with atrial fibrillation starting warfarin was significantly elevated during the first month of treatment. This early elevated risk increased with previous stroke history and higher baseline CHADS 2 score.
The overall 5-year risk of stroke observed in our study (1.8% PPY) is comparable with the annual incidence rate of 1.66% (95% confidence interval, 1.41%-1.91%) reported in a meta-analysis of 8 randomized controlled trials and an observational study by Azoulay et al, 3, 5 but higher than the rate of 1.17% PPY reported in another observational study of younger patients with lower CHADS 2 scores. 1 The explanation for our findings is likely multifactorial. The results may reflect the high-risk period after a transient ischemic attack, 6 and the time required to achieve therapeutic anticoagulation. Less frequent international normalized ratio testing may have been a contributor. More research is needed to elucidate whether a transient hypercoagulable state seen immediately after warfarin initiation explains our findings. 7 Our sensitivity 
Stroke
April 2015 analysis stratifying patients by timing of warfarin initiation after atrial fibrillation diagnosis found similar stroke rates in both groups. This suggests our findings are not simply influenced by elevated rates of stroke after atrial fibrillation diagnosis, as has been previously reported. 8 Moreover, few patients received heparins or antiplatelet agents before initiating warfarin. Studies are needed to determine whether bridging therapy, antiplatelet therapy, or use of direct-acting anticoagulants mitigate this early increased stroke risk. Strengths of this study include its large, populationbased sample and long follow-up. Limitations include our inability to assess the quality of anticoagulation. We also could not capture stroke events that did not result in hospitalization or some important risk factors for stroke, such as hypertension.
Conclusions
In this large, population-based cohort study of older patients with atrial fibrillation, we observed the highest rate of ischemic stroke in the first 30 days after warfarin initiation. Although this does not provide evidence of a causal link between warfarin initiation and stroke, the persistence of thromboembolic risk despite anticoagulation highlights the need for future research in this area.
Figure.
Rate of ischemic stroke among new warfarin users with atrial fibrillation.
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Stroke April 2015 analysis stratifying patients by timing of warfarin initiation after atrial fibrillation diagnosis found similar stroke rates in both groups. This suggests our findings are not simply influenced by elevated rates of stroke after atrial fibrillation diagnosis, as has been previously reported. 8 Moreover, few patients received heparins or antiplatelet agents before initiating warfarin. Studies are needed to determine whether bridging therapy, antiplatelet therapy, or use of direct-acting anticoagulants mitigate this early increased stroke risk. Strengths of this study include its large, populationbased sample and long follow-up. Limitations include our inability to assess the quality of anticoagulation. We also could not capture stroke events that did not result in hospitalization or some important risk factors for stroke, such as hypertension.
Conclusions
